Idiotypic vaccination with a murine anti-dsDNA antibody: phase I study in patients with nonactive systemic lupus erythematosus with nephritis
- PMID: 10606369
Idiotypic vaccination with a murine anti-dsDNA antibody: phase I study in patients with nonactive systemic lupus erythematosus with nephritis
Abstract
Objective: To determine the safety and immunogenicity of an idiotypic anti-dsDNA vaccine in patients with nonactive systemic lupus erythematosus (SLE) and stable lupus nephritis.
Methods: Patients with SLE with a history of nephritis were randomized for vaccination with the murine anti-dsDNA monoclonal antibody (Mab) 3E10 in a dose ranging, double blind, placebo controlled study (phase I).
Results: Of the 9 patients injected with Mab 3E10, 5 showed a human anti-mouse antibody (HAMA) response, in large part antiidiotypic, which developed within the first 3 months in 3 strong HAMA responders, and more than one year after immunization in an initially weak HAMA responder. All but one nonresponder were receiving low dose prednisone. No adverse events, in particular no evidence of lupus flares, and no untoward laboratory findings were reported over a followup of 2 years.
Conclusion: In patients with stable lupus nephritis, immunization with Mab 3E10 appears safe and can generate a significant antiidiotypic response. Idiotypic vaccination may be an approach to specific immunotherapy of autoimmune lupus nephritis.
Similar articles
-
Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.Arthritis Rheum. 2005 Feb;52(2):522-30. doi: 10.1002/art.20862. Arthritis Rheum. 2005. PMID: 15693007
-
A conserved anti-DNA antibody idiotype associated with nephritis in murine and human systemic lupus erythematosus.J Immunol. 1990 Apr 1;144(7):2653-8. J Immunol. 1990. PMID: 2319132
-
Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.Arthritis Rheum. 2000 Feb;43(2):429-39. doi: 10.1002/1529-0131(200002)43:2<429::AID-ANR25>3.0.CO;2-N. Arthritis Rheum. 2000. PMID: 10693885
-
[Immunology in medical practice. III. Disseminated lupus erythematosus: disturbed apoptosis?].Ned Tijdschr Geneeskd. 1997 Sep 27;141(39):1848-54. Ned Tijdschr Geneeskd. 1997. PMID: 9545742 Review. Dutch.
-
[Role of the nucleosome in the physiopathology of systemic lupus erythematosus].Ann Med Interne (Paris). 2003 Feb;154(1):25-32. Ann Med Interne (Paris). 2003. PMID: 12746656 Review. French.
Cited by
-
Targeted heat shock protein 72 for pulmonary cytoprotection.Ann N Y Acad Sci. 2016 Jun;1374(1):78-85. doi: 10.1111/nyas.13059. Epub 2016 May 6. Ann N Y Acad Sci. 2016. PMID: 27152638 Free PMC article. Review.
-
Central Nervous System Delivery and Biodistribution Analysis of an Antibody-Enzyme Fusion for the Treatment of Lafora Disease.Mol Pharm. 2019 Sep 3;16(9):3791-3801. doi: 10.1021/acs.molpharmaceut.9b00396. Epub 2019 Aug 2. Mol Pharm. 2019. PMID: 31329461 Free PMC article.
-
Immunomodulatory potential of anti-idiotypic antibodies for the treatment of autoimmune diseases.Future Sci OA. 2020 Oct 29;7(2):FSO648. doi: 10.2144/fsoa-2020-0142. Future Sci OA. 2020. PMID: 33437514 Free PMC article. Review.
-
Targeting cancer with a lupus autoantibody.Sci Transl Med. 2012 Oct 24;4(157):157ra142. doi: 10.1126/scitranslmed.3004385. Sci Transl Med. 2012. PMID: 23100628 Free PMC article.
-
B lymphocytes and systemic lupus erythematosus.Curr Rheumatol Rep. 2003 Aug;5(4):264-9. doi: 10.1007/s11926-003-0004-x. Curr Rheumatol Rep. 2003. PMID: 14531953 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical